Lesions / Genital warts EM code is likely your best bet

Why This Topic Matters

Correctly identifying the appropriate coding approach for genital wart treatment affects claim accuracy and reduces the risk of denials when topical chemotherapy or other lesion treatment methods are documented.

Article Sections

1. CPT guidance for topical chemotherapy and office visits

   Introduces the general CPT framework discussed in the article and the relationship between topical chemotherapy treatment and office visit reporting.

2. Lesion destruction coding in the female genital system

   Reviews the CPT lesion destruction context for female genital system services and the broader issue of how chemical treatment is treated in that section.

3. Chemical treatment of genital warts and coding uncertainty

   Summarizes the discussion of genital wart treatment methods, the ambiguity around chemical treatment terminology, and why the topic can be confusing for coders.

4. Male genital lesion destruction codes

   Covers the separate CPT coding context for male genital lesion destruction and the comparison made to other treatment approaches.

5. Conflicting guidance and payer verification

   Explains the article’s discussion of conflicting CPT references and the need to confirm payer-specific policies.